RAM (RYAM) Q3 2026 Earnings Call Transcript

RAM (RYAM) reported flat to declining cellulose pricing in Q3 2026, with lower-priced commodity products offsetting the strength of specialty products. The company aims to shift production mix to favor higher-margin Cellulose Specialties (CS) products, citing strong customer relationships and unique product characteristics. RYAM expects to conclude its strategic review in Q1 2027, delayed by U.S. tariffs on Canadian paperboard.

Original reporting
Published Nov 4, 2026, 7:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 7:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RAM (RYAM) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$RYAMBearishMed
01

Why it matters

The delayed review timeline and focus on shifting production mix may weigh on the stock, while higher CS pricing offers upside if execution improves.

02

Market read

Management’s update on the strategic review and product mix is material for investors tracking RYAM’s earnings volatility and sector positioning.

03

What to watch

Potential upside from higher‑margin CS product pricing if mix shift succeeds faster than management suggests.

Relevance 6/10Novelty 6/10Timing: post‑earnings call today

Background

Rayonier Advanced Materials (RYAM) provided an earnings call transcript discussing Q3 performance, pricing dynamics, and a strategic review timeline.

Company-level read

Ticker impact

$RYAMBearishHigh confidence
Context

Management updated the strategic review timeline, now targeting a Q1 2027 conclusion instead of Q4, and discussed pricing and mix shifts for the Cellulose Specialties business.

Expected impact

likely pressure as investors price in a slower strategic review and ongoing commodity exposure

Evidence & confidence

Management’s admission of a later review completion and emphasis on reducing commodity exposure indicate uncertainty and may dampen the stock until clearer outcomes are disclosed.

Market effects

Highlights challenges in the cellulose specialty sector, potentially prompting peers to reassess commodity exposure.

May affect North American pulp and paper stocks as the review timeline shift signals sector‑wide headwinds.

Limited to specialty chemicals and pulp industry investors.

Counterpoint

If the strategic review yields a sale or spin‑off, the stock could rally on a later‑stage catalyst.

Key entities

  • Rayonier Advanced Materials

    US‑listed pulp and specialty chemicals producer (ticker RYAM).

Related articles

$RYAMMedAI 8/10

Rayonier Advanced Materials Q3 Earnings Call Highlights

Rayonier Advanced Materials (RYAM) reported Q3 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose to $52M. High Purity Cellulose sales increased, while Paperboard & High Yield Pulp sales declined. The company is focusing on its Cellulose Specialties franchise and expects positive free cash flow for 2026, subject to certain conditions.

$RYAMMed

Rayonier Advanced Materials Inc (RYAM) Q3 2026 Earnings Call Highlights: HPC Segment

Rayonier Advanced Materials (RYAM) reported Q3 2026 net sales of $383M, up 2% sequentially and 8% YoY. Adjusted EBITDA rose 30% to $52M. CEO Dan Kraupchak discussed strategic plans, including optimizing production mix and pursuing longer-term customer agreements. CFO Marcus Moltner noted $4M energy credits and $2M tariff-related costs. CS volumes are expected to exit the year at ~100,000 metric tons per quarter. Liquidity stands at $143M, with positive adjusted free cash flow of $2M YTD.

$RYAMHighAI 8/10

Rayonier Advanced Materials 3Q 2026: Revenue $382.51M, Net income ($229.77M), EPS ($3.4) — 10-Q Summary

Rayonier Advanced Materials reported 3Q 2026 revenue of $382.51M, up 8.4% YoY, but net loss widened to $229.77M. EPS loss was $3.4. Sales growth was driven by higher cellulose specialties pricing and increased volumes. The company idled uneconomic operations at Temiscaming and is targeting CS-focused production growth. A strategic review is expected to complete in Q1 2027.

$RYAMMed

RYAM Reports Third Quarter 2026 Results

RAYONIER ADVANCED MATERIALS INC. (RYAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. RYAM Reports Third Quarter 2026 Results Delivers 30% sequential growth in Adjusted EBITDA Temiscaming production economically idled following U.S. tariffs • Loss from Continuing Operations of $229 million adjusted for non-cash impairments of $221 million was $8 million, a 60% seq

$RYAMHighAI 8/10

RYAM Reports Third Quarter 2026 Results

Rayonier Advanced Materials (RYAM) reported Q3 2026 results. HPC income rose to $29M with Adjusted EBITDA of $44M, while Temiscaming operations were idled. Consolidated Adjusted EBITDA was $52M, including tariff costs. The company aims to conclude its strategic review in Q1 2027. Net sales were $383M, with HPC at $313M and Paperboard & High Yield Pulp at $70M. Operating loss was $196M, including non-cash impairments. Year-to-date Adjusted Free Cash Flow was $66M.

$RYAMMed

Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another Story

Rayonier Advanced Materials (RYAM) reported Q2 net sales of $376M, up 18% QoQ and 11% YoY, with a narrowed loss of $33M. High Purity Cellulose segment saw a 21% YoY price increase, boosting operating income by 45%. However, Cellulose Specialties volume fell 23% YoY. Management maintains a 2026 outlook for positive free cash flow and targets Q4 2026 for a strategic review conclusion.